References
- HaJ , ChaudhriA , AvirineniA , PanJ-J. Burden of hepatocellular carcinoma among hispanics in South Texas: a systematic review. Biomark. Res.5, 15 (2017).
- PhamC , FongT-L , ZhangJ , LiuL. Striking racial/ethnic disparities in liver cancer incidence rates and temporal trends in California, 1988–2012. J. Natl Cancer Inst.110(11), 1259–1269 (2018).
- AjayiF , JanJ , SingalAG , RichNE. Racial and sex disparities in hepatocellular carcinoma in the USA. Curr. Hepatol. Rep.19(4), 462–469 (2020).
- KubickaS , RudolphKL , HankeMet al.Hepatocellular carcinoma in Germany: a retrospective epidemiological study from a low-endemic area. Liver20(4), 312–318 (2000).
- CabibboG , MaidaM , GencoCet al.Natural history of untreatable hepatocellular carcinoma: a retrospective cohort study. World J. Hepatol.4(9), 256–261 (2012).
- TruittK , KhanSS , GregoryDL , ChuziS , VanWagnerLB. Deaths from hepatocellular carcinoma are more likely to occur in medical facilities than deaths from other cancers: 2003–2018. Liver Int.41(7), 1489–1493 (2021).
- SoodA , MidhaV , GoyalO , GoyalP , SoodN , SharmaSK. Profile of hepatocellular carcinoma in a tertiary care hospital in Punjab in northern India. Indian J. Gastroenterol.33(1), 35–40 (2014).
- LeVQ , NguyenVH , NguyenVHet al.Epidemiological characteristics of advanced hepatocellular carcinoma in the northern region of Vietnam. Cancer Control.26(1), 1073274819862793 (2019).
- FengH , LiB , LiZ , WeiQ , RenL. PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma. BMC Cancer21(1), 401 (2021).
- YuNC , ChaudhariV , RamanSSet al.CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis. Clin. Gastroenterol. Hepatol.9(2), 161–167 (2011).
- WangG , ZhuS , LiX. Comparison of values of CT and MRI imaging in the diagnosis of hepatocellular carcinoma and analysis of prognostic factors. Oncol. Lett.17(1), 1184–1188 (2019).
- BruixJ , ShermanM. American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology53(3), 1020–1022 (2011).
- CannellaR , TaibbiA , PorrelloG , DioguardiBurgio M , CabibboG , BartolottaTV. Hepatocellular carcinoma with macrovascular invasion: multimodality imaging features for the diagnosis. Diagn. Interv. Radiol.26(6), 531–540 (2020).
- ShindohJ , AndreouA , AloiaTAet al.Microvascular invasion does not predict long-term survival in hepatocellular carcinoma up to 2 cm: reappraisal of the staging system for solitary tumors. Ann. Surg. Oncol.20(4), 1223–1229 (2013).
- Mähringer-KunzA , SteinleV , KloecknerRet al.The impact of portal vein tumor thrombosis on survival in patients with hepatocellular carcinoma treated with different therapies: a cohort study. PLoS ONE16(5), e0249426 (2021).
- CatalanoOA , ChoyG , ZhuA , HahnPF , SahaniDV. Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging. Radiology254(1), 154–162 (2010).
- MarreroJA , KulikLM , SirlinCBet al.Diagnosis, staging, and management of hepatocellular carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology68(2), 723–750 (2018).